Alzheimers Disease Therapeutics and Diagnostics Market is segmented on the basis of therapeutics, diagnostics and geography. According to the therapeutics, the market is segmented into, marketed drugs such as Cholinesterase inhibitors and NMDA receptor antagonist, and Pipeline Drugs. On the basis of diagnostics, the market is segmented into Lumbar puncture test, Computed tomography (CT) scan, Magnetic resonance imaging (MRI), Electroencephalography (EEG), Positron emission tomography (PET) scan and Others. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- Pfizer, Inc.
- Eisai Co., Ltd.
- Novartis AG
- H. Lundbeck A/S
- Forest Laboratories, Inc.
- TauRx Therapeutics Ltd
- AC Immun
- Johnson and Johnson
- GE Healthcare
- Siemen Healthineers
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-toc-and-sample/1441
๐๐๐ญ ๐๐ฉ ๐๐จ ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ, ๐๐ข๐ฅ๐ฅ ๐ญ๐ก๐ ๐๐๐ญ๐ ๐๐๐ญ๐ก ๐จ๐ ๐๐ฎ๐ ๐ฎ๐ฌ๐ญ ๐๐๐๐.
Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. The global Alzheimers disease market has observed tremendous growth in the recent years, owing to the high prevalence of Alzheimers disease and increased life expectancy of population. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Presently, very few therapeutic alternatives are available in the market and none of them provide a complete cure for this condition. This indicates an impending market need that would provide lucrative growth opportunities to the industry players.
Rising old age population and higher incidences of neurodegenerative diseases are two significant factors that supplement the market growth. Moreover, increasing R&D investment and a large number of drugs in the pipeline are further expected to fuel the market growth. However, high cost of treatment and lack of transparent reimbursements are likely to curtail the market growth.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1441
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- Comprehensive analysis of factors that drive and restrict the growth of the Alzheimers Disease Therapeutics and Diagnostics Market is provided
- The report provides a comprehensive analysis of the current market and estimations through 20142020, which would enable the stakeholders to capitalize on prevailing market opportunities
- An in-depth analysis of key segments of the market demonstrate the types of therapeutics along with the diagnostics that are currently used in the Alzheimers Disease market
- SWOT analysis highlights the internal environment of leading companies for strategy formulation
- The Alzheimers disease market scenario is comprehensively analysed in accordance to the key regions
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
๐๐ฅ๐ฌ๐จ ๐๐๐๐ ๐๐ฒ ๐๐ฅ๐จ๐ ๐ฌ
Singapore Flow Cytometry Boosting Technologies, Industry Growth, Demand Status, Trends
Singapore Stem Cell Umbilical Cord Blood Current Trends and Future Scenarios
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com